Bios Partners is a private equity firm based in Dallas/Fort Worth. Bios Partners invests in early seed opportunities as well as later-stage growth companies, with a focus on biotech and medical devices companies.
Bios Partners is a venture capital firm based In Dallas/Ft. Worth focused on investment in innovative early-stage and growth-stage biotech and medical device companies.
Bios Partners was founded in 2014 by Leslie Wayne Kreis Jr. and Aaron G. L. Fletcher.
Bios Partners has made 7 investments. One such investment was on Jan 23, 2019, when they invested $10M in Incysus Therapeutics. Bios Partners has raised a total of $5M in a single venture fund, Bios Fund II NT. This fund was announced on Oct 1, 2018, and raised a total of $5M.
Therapeutics for lung injury and disease company
A company based in Farmington, Connecticut, that develops skin disease treatments using microbiome science and technology.
410 Medical Inc is a Durham, North Carolina-based medical device company.